2012 Tuberous Sclerosis Complex Clinical Trial Award Program
by:
Iola BonggayThe United States Department of Defense, otherwise known as DOD, is a federal government agency that is generally in-charge of coordinating and supervising all agencies and functions of the government relating directly to national security and the United States armed forces.
The grants and programs of the DOD are all entirely designed to assist in the realization of its overall agency mission which is to "provide the military forces needed to deter war and to protect the security of our country."
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).
Initially, the primary objective of the Tuberous Sclerosis Complex Clinical Trial Award Program is to encourage the execution of innovative research studies aimed at understanding the pathogenesis of TSC and ultimately, translate these findings to the care of individuals with TSC.
(continued...)
2012 Tuberous Sclerosis Complex Clinical Trial Award Program
Page 2
About The Author
Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs.
She also maintains Websites providing resources on
community grants and health grants.
|
Additional Resources
category - Health Grants
Early-Stage Innovative Technology Development for Cancer Research ProgramThe National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.
Development of Measures to Determine Successful Hearing Health Care OutcomesIn accordance with this mission, the National Institutes of Health has recently collaborated with the National Institute on Deafness and Other Communication Disorders (NIDCD) in an attempt to constitute the Development of Measures to Determine Successful Hearing Health Care Outcomes Program.
Health Care Fraud Program Expansion and Senior Medical Patrol Capacity Building Grants In line with this mission, the Administration on Aging has recently established the Health Care Fraud Program Expansion and Senior Medical Patrol Capacity Building Grants in an attempt to boost the capacity of the Senior Medicare Patrol (SMP) program to reach more Medicare and Medicaid beneficiaries, their families and caregivers, while focusing on fraud prevention and identification.
Development of Therapeutics and Diagnostics for Biodefense ProgramThe National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.